MX9204030A - Formulacion farmaceutica local de aceite en agua o acuosa y metodo para su preparacion. - Google Patents
Formulacion farmaceutica local de aceite en agua o acuosa y metodo para su preparacion.Info
- Publication number
- MX9204030A MX9204030A MX9204030A MX9204030A MX9204030A MX 9204030 A MX9204030 A MX 9204030A MX 9204030 A MX9204030 A MX 9204030A MX 9204030 A MX9204030 A MX 9204030A MX 9204030 A MX9204030 A MX 9204030A
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- water
- pharmaceutical formulation
- aqueous
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919114939A GB9114939D0 (en) | 1991-07-11 | 1991-07-11 | Pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9204030A true MX9204030A (es) | 1993-02-01 |
Family
ID=10698164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9204030A MX9204030A (es) | 1991-07-11 | 1992-07-09 | Formulacion farmaceutica local de aceite en agua o acuosa y metodo para su preparacion. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0593562B1 (es) |
JP (1) | JP2865867B2 (es) |
KR (1) | KR100245016B1 (es) |
AT (1) | ATE177638T1 (es) |
AU (2) | AU2230792A (es) |
CA (1) | CA2113080C (es) |
DE (1) | DE69228686T2 (es) |
DK (1) | DK0593562T3 (es) |
ES (1) | ES2128353T3 (es) |
GB (1) | GB9114939D0 (es) |
GR (1) | GR3029886T3 (es) |
HK (1) | HK1012242A1 (es) |
IE (1) | IE922263A1 (es) |
MX (1) | MX9204030A (es) |
NZ (1) | NZ243490A (es) |
PT (1) | PT100670B (es) |
TW (1) | TW328049B (es) |
WO (1) | WO1993000905A1 (es) |
ZA (1) | ZA925130B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124304A (en) * | 1993-10-05 | 2000-09-26 | Smithkline Beecham Plc | Penciclovir for the treatment of zoster associated pain |
GB9326177D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Pharmaceuticals |
IT1287114B1 (it) * | 1996-10-31 | 1998-08-04 | Recordati Chem Pharm | Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir |
US7223387B2 (en) | 1998-11-18 | 2007-05-29 | Medivir Ab | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
GB9828620D0 (en) * | 1998-12-23 | 1999-02-17 | Glaxo Group Ltd | Medicaments |
CN109481674A (zh) * | 2018-11-14 | 2019-03-19 | 大连亚维药业有限公司 | 一种生物无菌乳膏药物的生产方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8917959D0 (en) * | 1989-08-05 | 1989-09-20 | Beecham Group Plc | Pharmaceutical formulation |
GB9001886D0 (en) * | 1990-01-26 | 1990-03-28 | Beecham Group Plc | Pharmaceutical formulation |
-
1991
- 1991-07-11 GB GB919114939A patent/GB9114939D0/en active Pending
-
1992
- 1992-07-03 WO PCT/GB1992/001208 patent/WO1993000905A1/en active IP Right Grant
- 1992-07-03 EP EP92914132A patent/EP0593562B1/en not_active Expired - Lifetime
- 1992-07-03 AT AT92914132T patent/ATE177638T1/de active
- 1992-07-03 AU AU22307/92A patent/AU2230792A/en not_active Abandoned
- 1992-07-03 KR KR1019940700069A patent/KR100245016B1/ko not_active IP Right Cessation
- 1992-07-03 DE DE69228686T patent/DE69228686T2/de not_active Expired - Lifetime
- 1992-07-03 DK DK92914132T patent/DK0593562T3/da active
- 1992-07-03 JP JP5502081A patent/JP2865867B2/ja not_active Expired - Lifetime
- 1992-07-03 CA CA002113080A patent/CA2113080C/en not_active Expired - Lifetime
- 1992-07-03 ES ES92914132T patent/ES2128353T3/es not_active Expired - Lifetime
- 1992-07-09 ZA ZA925130A patent/ZA925130B/xx unknown
- 1992-07-09 MX MX9204030A patent/MX9204030A/es active IP Right Grant
- 1992-07-09 PT PT100670A patent/PT100670B/pt not_active IP Right Cessation
- 1992-07-09 NZ NZ243490A patent/NZ243490A/en not_active IP Right Cessation
- 1992-07-10 IE IE226392A patent/IE922263A1/en not_active IP Right Cessation
- 1992-08-12 TW TW080101931A02A patent/TW328049B/zh not_active IP Right Cessation
-
1995
- 1995-12-14 AU AU40401/95A patent/AU698847B2/en not_active Expired
-
1998
- 1998-12-15 HK HK98113478A patent/HK1012242A1/xx not_active IP Right Cessation
-
1999
- 1999-04-05 GR GR990400976T patent/GR3029886T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69228686D1 (de) | 1999-04-22 |
AU4040195A (en) | 1996-02-22 |
ES2128353T3 (es) | 1999-05-16 |
PT100670B (pt) | 1999-07-30 |
GR3029886T3 (en) | 1999-07-30 |
CA2113080A1 (en) | 1993-01-21 |
TW328049B (en) | 1998-03-11 |
EP0593562A1 (en) | 1994-04-27 |
ZA925130B (en) | 1993-05-05 |
KR100245016B1 (ko) | 2000-03-02 |
EP0593562B1 (en) | 1999-03-17 |
DK0593562T3 (da) | 1999-09-27 |
DE69228686T2 (de) | 1999-09-09 |
AU698847B2 (en) | 1998-11-12 |
IE922263A1 (en) | 1993-01-13 |
GB9114939D0 (en) | 1991-08-28 |
HK1012242A1 (en) | 1999-07-30 |
AU2230792A (en) | 1993-02-11 |
JPH06508845A (ja) | 1994-10-06 |
ATE177638T1 (de) | 1999-04-15 |
CA2113080C (en) | 2003-02-25 |
WO1993000905A1 (en) | 1993-01-21 |
PT100670A (pt) | 1993-10-29 |
NZ243490A (en) | 1995-03-28 |
JP2865867B2 (ja) | 1999-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITBO910476A0 (it) | -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali. | |
ES2061768T3 (es) | Agente para tratamiento del cabello con productos de contenido natural. | |
AR018109A1 (es) | FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA | |
BR9713677A (pt) | Formulações em gel para liberação tópica de droga | |
NO874150L (no) | Preparater inneholdende propylenglykol og/eller polyetylenglykol og urinstoff som aktive hovedkomponenter og anvendelse derav. | |
FI875272A (fi) | Baerarloesningsmedelssystem i tvao fas. | |
ITRM920270A0 (it) | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. | |
ES2044843T3 (es) | Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos. | |
DE3685696D1 (de) | Melatoninhaltige mittel sowie deren verwendungen. | |
MX9204030A (es) | Formulacion farmaceutica local de aceite en agua o acuosa y metodo para su preparacion. | |
IT1260638B (it) | Sistema per la preparazione di un fluido da utilizzare in trattamenti medicali | |
ITRM930286A0 (it) | Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego. | |
MY110074A (en) | Pharmacuetical formulation. | |
ATE5073T1 (de) | 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
KR910004186A (ko) | 제약학적 배합물 | |
MX9201932A (es) | Aparato plegable para lograr y mantener la ereccion del pene. | |
ITMI912466A1 (it) | Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche | |
ES2101311T3 (es) | Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer. | |
ES2190499T3 (es) | Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer. | |
SE8802257D0 (sv) | Antimikrobiell komposition | |
ITGE940025A0 (it) | Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi. | |
ITRM920351A0 (it) | Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose. | |
MC2450A1 (fr) | Composition pour le traitement topique d'affections de la peau et des phanères | |
ITRM940505A0 (it) | "agente attivo per il trattamento di infezioni croniche da immunodepressione e per contrastare lo sviluppo di tumori favoriti da immunodepressione". | |
FI941707A (fi) | Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |